Targeting tumor-associated macrophages for cancer immunotherapy.

No abstract is available for this paper.

• Publication year

  2022

• Venue

  International Review of Cell and Molecular Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/bs.ircmb.2022.02.002PMID 35636930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of Intra-Tumoral Macrophages and T Cells in Non-Small Cell Lung Cancer (NSCLC) Indicates a Role for Immune Checkpoint and CD200-CD200R Interactions

  2021cited by this paper
• Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors

  2021cited by this paper
• Function of Macrophages in Disease: Current Understanding on Molecular Mechanisms

  2021cited by this paper
• Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy

  2021cited by this paper
• Toll-like Receptor 2 in Autoimmune Inflammation

  2021cited by this paper
• Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer

  2021cited by this paper
• Targeting macrophages in cancer immunotherapy

  2021cited by this paper
• Crosstalk between Macrophages and Pancreatic β-Cells in Islet Development, Homeostasis and Disease

  2021cited by this paper
• Therapeutic targeting of tumor-associated macrophages.

  2021cited by this paper
• Targeting tumor-associated macrophages to synergize tumor immunotherapy

  2021cited by this paper
• Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage

  2021cited by this paper
• Manipulating the function of tumor-associated macrophages by siRNA-loaded lipid nanoparticles for cancer immunotherapy.

  2020cited by this paper
• The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy

  2020cited by this paper
• Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.

  2020cited by this paper
• A Ten-Year-Old Boy with Antiepileptic Drugs-Induced DRESS Syndrome

  2020cited by this paper
• Matrix Metalloproteinases' Role in Tumor Microenvironment.

  2020cited by this paper
• Diversity, Mechanisms, and Significance of Macrophage Plasticity.

  2020cited by this paper
• Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019

  2020cited by this paper
• Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.

  2020cited by this paper
• Targeting tumor‐associated macrophages: A potential treatment for solid tumors

  2020cited by this paper
• Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

  2020cited by this paper
• Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach

  2020cited by this paper
• M1hot tumor-associated macrophages boost tissue-resident memory T cells infiltration and survival in human lung cancer

  2020cited by this paper
• COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis

  2020cited by this paper
• Macrophage checkpoint blockade: results from initial clinical trials, binding analyses, and CD47-SIRPα structure–function

  2020cited by this paper
• Macrophages in Organ Transplantation

  2020cited by this paper
• Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

  2020cited by this paper
• Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development

  2020cited by this paper
• Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients

  2020cited by this paper
• Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice

  2020cited by this paper
• Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity

  2020cited by this paper
• Marginal zone SIGN-R1+ macrophages are essential for the maturation of germinal center B cells in the spleen

  2020cited by this paper
• Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment

  2020cited by this paper
• Ontogeny of Tumor-Associated Macrophages

  2019cited by this paper
• Role of Matrix Metalloproteinases in Angiogenesis and Cancer

  2019cited by this paper
• The Two Faces of Tumor-Associated Macrophages and Their Clinical Significance in Colorectal Cancer

  2019cited by this paper
• CCR5 is a required signaling receptor for macrophage expression of inflammatory genes in response to viral double-stranded RNA.

  2019cited by this paper
• Harnessing tumor-associated macrophages as aids for cancer immunotherapy

  2019cited by this paper
• Phagocytosis checkpoints as new targets for cancer immunotherapy

  2019cited by this paper
• Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1

  2019cited by this paper
• The Role of Macrophages in HIV-1 Persistence and Pathogenesis

  2019cited by this paper
• Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers

  2019cited by this paper
• Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy.

  2019cited by this paper
• Targeting Trop-2 in solid tumors: future prospects

  2019cited by this paper
• Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents.

  2019cited by this paper
• Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro

  2019cited by this paper
• Biological Effects of Nanoparticles on Macrophage Polarization in the Tumor Microenvironment

  2019cited by this paper
• Macrophage Polarization in Physiological and Pathological Pregnancy

  2019cited by this paper
• Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma

  2019cited by this paper
• VEGF-A drives TOX-dependent T cell exhaustion in anti–PD-1–resistant microsatellite stable colorectal cancers

  2019cited by this paper
• IL-10 secreted by cancer-associated macrophages regulates proliferation and invasion in gastric cancer cells via c-Met/STAT3 signaling

  2019cited by this paper
• Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release

  2019cited by this paper
• IL‐10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF‐κB/Notch1 pathway in non‐small cell lung cancer

  2019cited by this paper
• The Macrophage 'Do not eat me' signal, CD47, is a clinically validated cancer immunotherapy target.

  2019cited by this paper
• Human PI3Kγ deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathology

  2019cited by this paper
• SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma

  2019cited by this paper
• Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets

  2019cited by this paper
• Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response

  2019cited by this paper
• Notch signaling via Wnt regulates the proliferation of alternative, CCR2-independent tumor-associated macrophages in hepatocellular carcinoma.

  2019cited by this paper
• PI3Kgamma Inhibitor Attenuates Immunosuppressive Effect of Poly(l‐Glutamic Acid)‐Combretastatin A4 Conjugate in Metastatic Breast Cancer

  2019cited by this paper
• Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis.

  2019cited by this paper
• CD24 signalling through macrophage Siglec-10 is a new target for cancer immunotherapy

  2019cited by this paper
• Targeting Tumor-Associated Macrophages in Cancer.

  2019cited by this paper
• Regulation of macrophage activity by surface receptors contained within Borrelia burgdorferi-enriched phagosomal fractions

  2019cited by this paper
• Role of Human Macrophage Polarization in Inflammation during Infectious Diseases

  2018cited by this paper
• Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson’s Disease?

  2018cited by this paper
• High-Resolution Mapping and Dynamics of the Transcriptome, Transcription Factors, and Transcription Co-Factor Networks in Classically and Alternatively Activated Macrophages

  2018cited by this paper
• Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response

  2018cited by this paper
• TLR-3 Stimulation Skews M2 Macrophages to M1 Through IFN-αβ Signaling and Restricts Tumor Progression

  2018cited by this paper
• Molecular Repolarisation of Tumour-Associated Macrophages

  2018cited by this paper
• Toll-Like Receptors Drive Specific Patterns of Tolerance and Training on Restimulation of Macrophages

  2018cited by this paper
• Red pulp macrophages in the human spleen are a distinct cell population with a unique expression of Fc-γ receptors.

  2018cited by this paper
• Blocking "don't eat me" signal of CD47-SIRPα in hematological malignancies, an in-depth review.

  2018cited by this paper
• Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity

  2018cited by this paper
• Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages

  2018cited by this paper
• Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages.

  2018cited by this paper
• Targeting macrophages: therapeutic approaches in cancer

  2018cited by this paper
• CD47 Blockade by Hu5F9‐G4 and Rituximab in Non‐Hodgkin's Lymphoma

  2018cited by this paper
• Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated ‘don’t eat me signal’.

  2018cited by this paper
• The Role of Toll-Like Receptors in the Production of Cytokines by Human Lung Macrophages

  2018cited by this paper
• Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges

  2018cited by this paper
• Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion

  2018cited by this paper
• Targeting Macrophages in Cancer: From Bench to Bedside

  2018cited by this paper
• Alveolar Macrophages.

  2018cited by this paper
• Notch Signaling in Macrophages in the Context of Cancer Immunity

  2018cited by this paper
• Alveolar Macrophages in the Resolution of Inflammation, Tissue Repair, and Tolerance to Infection

  2018cited by this paper
• Tumor targeting via EPR: Strategies to enhance patient responses.

  2018cited by this paper
• Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity

  2018cited by this paper
• Perivascular macrophages in health and disease

  2018cited by this paper
• Defining the role of the tumor vasculature in antitumor immunity and immunotherapy

  2018cited by this paper
• T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes

  2017cited by this paper
• Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity

  2017cited by this paper
• Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma

  2017cited by this paper
• Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy

  2017cited by this paper
• Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages

  2017cited by this paper
• Development of autoantibodies precedes clinical manifestations of autoimmune diseases: A comprehensive review.

  2017cited by this paper
• Tumor-associated macrophages: from basic research to clinical application

  2017cited by this paper
• Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy

  2017cited by this paper
• Tumor-Associated Macrophages as Target for Antitumor Therapy

  2017cited by this paper
• Preclinical and clinical aspects of TNF-α and its receptors TNFR1 and TNFR2 in breast cancer

  2017cited by this paper

• Therapeutic targeting of toll-like receptor pathways in tumor-associated macrophages.

  2026cites this paper
• Advances in cancer immunotherapy: historical perspectives, current developments, and future directions

  2025cites this paper
• SIRPα + CD209 + cell: a specialized antigen-presenting cell that contributes to anti-SIRPα/RT therapy in colorectal cancer

  2025cites this paper
• Exploring the regulatory role of CNPY3 as a prognostic biomarker on human glioma cell migration, invasion and immune infiltration

  2025cites this paper
• Machine learning-based screening and validation of liver metastasis-specific genes in colorectal cancer

  2024cites this paper
• Promoting macrophage phagocytosis of cancer cells for effective cancer immunotherapy.

  2024cites this paper
• Analysis of M2 macrophage-associated risk score signature in pancreatic cancer TME landscape and immunotherapy

  2023cites this paper
• Molecular determinants of immunogenic cell death elicited by radiation therapy

  2023cites this paper
• Dual impact of radiation therapy on tumor-targeting immune responses.

  2023cites this paper
• Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy

  2023cites this paper
• Hsa_circ_0009092/miR-665/NLK signaling axis suppresses colorectal cancer progression via recruiting TAMs in the tumor microenvironment

  2023cites this paper
• Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference

  2023cites this paper
• Recent advances in magnetic nanocarriers for tumor treatment.

  2023cites this paper
• Quantification of beta-galactosidase activity as a marker of radiation-driven cellular senescence.

  2023cites this paper
• Myeloid-derived suppressor cells: Emerging players in cancer and beyond.

  2023cites this paper
• Carbon dot-based nanomaterials: a promising future nano-platform for targeting tumor-associated macrophages

  2023cites this paper
• P-Hydroxylcinnamaldehyde induces tumor-associated macrophage polarization toward the M1 type by regulating the proteome and inhibits ESCC in vivo and in vitro.

  2023cites this paper
• Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse models

  2022cites this paper
• Targeted xCT‐mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti‐PD‐1/L1 Response

  2022cites this paper
• Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade

  2022cites this paper
• Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma

  2022cites this paper
• Overcoming T-cell exhaustion in glioblastoma: A narrative review

  2022cites this paper
• Multiple targeted self-emulsifying compound RGO reveals obvious anti-tumor potential in hepatocellular carcinoma

  2020cites this paper